Vimarsana
Biggest News Aggregation in the World

Imke Meyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Imke Meyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Imke Meyer Today - Breaking & Trending Today

Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals - Vimarsana News

Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals

Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals

Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals - Vimarsana News

Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals

Germany - Bayer and RTW Investments, LP today announced an equity investment into Ji Xing Pharmaceuticals Limited in the amount of USD 35 million and USD 127 million respectively. JIXING, founded...

Affini-T Therapeutics, Inc.: Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations - Vimarsana News

Affini-T Therapeutics, Inc.: Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations

Co-founded at Fred Hutchinson Cancer Research Center with Phil Greenberg, M.D., Aude Chapuis, M.D., and Tom Schmitt, Ph.D., and Vida Ventures along with serial entrepreneurs Arjun Goyal, M.D., M.Phil.